Related Experiment Video
Updated: Jun 19, 2026
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
35.2K
Enhancing patient selection for thyroid thermal ablation: insights from a multidisciplinary team approach
Sylvie Daclin1, Gilles Russ1,2,3, Sylvain Poiree1
1Thyroid Diseases and Endocrine Tumors Department, Pitié-Salpêtrière Hospital, Paris, France.
Summary
Multidisciplinary team meetings (MDTMs) identified non-benign thyroid nodules in 10% of patients excluded from thermal ablation (TA) despite benign cytology. Non-benign outcomes after TA were rare, highlighting MDTM importance in managing potential thyroid cancer.
Area of Science:
- Endocrinology
- Oncology
- Radiology
Background:
- Thermal ablation (TA) is a common treatment for benign thyroid nodules.
- A risk of occult malignancy persists even with two benign cytology results.
- Multidisciplinary team meetings (MDTMs) play a role in patient selection for TA.
Purpose of the Study:
- To determine the rate of non-benign histology in patients excluded from TA by MDTMs.
- To identify clinical and ultrasonographic predictors of malignancy in these patients.
- To assess the incidence of non-benign outcomes in patients who underwent TA and later surgery.
Main Methods:
- Retrospective single-center cohort study (January 2019 - December 2023).
- Analysis of patients referred for TA with two benign cytology results but excluded by MDTM.
- Review of patients treated with TA who subsequently underwent surgery.
Main Results:
- 131 of 573 patients (23%) were excluded from TA by MDTM.
- 6 of 61 surgically treated excluded patients (10%) had non-benign histology.
- 1.4% of TA-treated patients required surgery, with rare non-benign findings.
Conclusions:
- MDTM evaluation is crucial for identifying non-benign thyroid nodules prior to TA.
- Non-benign outcomes following TA are infrequent.
- Further research is needed due to the retrospective design and limited event numbers.
